Abstract
Biopharmaceutical drugs have transformed modern medicine, yet their manufacturing processes remain challenged by yield variability and rising production costs. This paper explores a promising application in a new domain to improve biomanufacturing efficiency through the backpass production method. Our production setting consists of two bioreactors: a dedicated bioreactor for production of a high-value product A, and a shared bioreactor for product A and a lower-value product B. The backpass method allows biomass to be transferred from the dedicated to the shared bioreactor, enabling additional production of product A while bypassing extensive upstream processing steps. We examine the performance of three backpass strategies, defined based on feedback from our industry partner, and use discrete event simulation to answer industry-specific questions related to the system's performance regarding throughput and profitability. This analysis provides practitioners with a decision-support framework for capital investments and operational planning.
| Original language | English |
|---|---|
| Title of host publication | 2025 Winter Simulation Conference, WSC 2025 |
| Pages | 905-916 |
| Number of pages | 12 |
| ISBN (Electronic) | 979-8-3315-8726-0 |
| DOIs | |
| Publication status | Published - 22 Jan 2026 |
Publication series
| Name | Winter Simulation Conference Proceedings |
|---|
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Dive into the research topics of 'Backpass in Biomanufacturing: Effective Strategies for Sharing Bioreactors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver